| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |